Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Bio-Reference Laboratories Inc. (BRLI)

-NasdaqGS

30.04 Up 0.79(2.70%) May 17, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 30, 2013Oct 30, 2012Jul 30, 2012Apr 29, 2012
Total Revenue 161,256   176,052   172,302   174,514  
Cost of Revenue90,334  88,807  86,253  83,908  
Gross Profit 70,922   87,245   86,049   90,606  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative41,641  39,135  39,177  39,772  
Non Recurring -   -   -   -  
Others13,522  24,707  24,199  34,061  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 15,759   23,403   22,673   16,773  
Income from Continuing Operations
Total Other Income/Expenses Net(86)(134)(110)42  
Earnings Before Interest And Taxes15,673  23,269  22,563  16,815  
Interest Expense300  302  382  413  
Income Before Tax15,373  22,967  22,181  16,402  
Income Tax Expense6,708  10,078  9,585  7,096  
Minority Interest -   -   -   -  
Net Income From Continuing Ops8,665  12,889  12,596  9,306  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 8,665   12,889   12,596   9,306  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 8,665   12,889   12,596   9,306  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.